GLMD - Galmed Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $651.93. This is a potential upside of $651.32 (106773.77%) from yesterday's end of day stock price of $0.61.

Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 14 price targets and 33 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.44% with an average time for these price targets to be met of 432.33 days.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 23-Jul-2023. First documented stock forecast 08-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$48

$46.96 (4515.38%)

2 years 6 months 23 days ago
(23-Jul-2023)

1/2 (50%)

$33.48 (230.58%)

89

Buy

3 years 6 months 8 days ago
(07-Aug-2022)

0/2 (0%)

$4172.4 (398.28%)

Buy

$13

3 years 6 months 11 days ago
(04-Aug-2022)

2/2 (100%)

$-34.55 (-72.66%)

291

Hold

3 years 8 months 29 days ago
(17-May-2022)

1/2 (50%)

$-541.2 (-59.07%)

580

Hold

3 years 8 months 29 days ago
(17-May-2022)

1/2 (50%)

$1481.4 (84.24%)

2101

Show more analysts

Please expand the browser size to see the chart

What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 432.33 days on average for the stock forecasts to be realized with a an average price target met ratio 44.44

Which analyst has the current highest performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Kolbert has 4 price targets and 5 ratings on GLMD

Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?

Adam Walsh with highest potential upside - $373.96

Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?